Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02111993 · ClinicalTrials.gov registry record · NA

Evaluating Myocardial Injury for Defibrillation Threshold Testing Methods for ICD Implantation

A NA study of Heart Failure and Cardiomyopathy, sponsored by University of California, San Diego.

Completed
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT02111993 is a NA study of Heart Failure and Cardiomyopathy that has completed, run by University of California, San Diego. The registered enrollment target is 60 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02111993, a NA study of Heart Failure and Cardiomyopathy, has completed, sponsored by University of California, San Diego.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is to evaluate myocardial injury, if any, as quantified by cardiac markers (Troponin-T) in defibrillation threshold (DFT) testing during implantation of implantable cardioverter defibrillators (ICDs) using the upper limit of vulnerability (ULV) method vs. standard defibrillation threshold method.

Interventions

  • DEVICE Standard Defibrillation Testing
  • DEVICE Upper Limit of Vulnerability Testing

Study Locations (1)

California

  • UCSD Sulpizio Cardiovascular Center - La Jolla

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2011-08
Est. Completion 2015-06
Phase NA

Sponsor

University of California, San Diego

775 total trials

What the Registry Record Tells You About NCT02111993

The ClinicalTrials.gov registry entry for NCT02111993 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (97% lower). The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Heart Failure appearing as the primary indexed condition, and to 2 interventions - of which Standard Defibrillation Testing is the first listed.

NCT02111993 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT02111993 about?

NCT02111993 is a clinical study titled "Evaluating Myocardial Injury for Defibrillation Threshold Testing Methods for ICD Implantation". The objective of this study is to evaluate myocardial injury, if any, as quantified by cardiac markers (Troponin-T) in defibrillation threshold (DFT) testing during implantation of implantable cardioverter defibrillators (ICDs) using the upper limit of vulnerability (ULV) method vs. standard defibri...

What is the current status of trial NCT02111993?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2011-08. Estimated completion is 2015-06.

What conditions does trial NCT02111993 study?

This clinical trial studies the following conditions: Heart Failure, Cardiomyopathy, Cardiac Arrhythmia.

What interventions are being tested in trial NCT02111993?

The interventions under investigation include: Standard Defibrillation Testing (DEVICE), Upper Limit of Vulnerability Testing (DEVICE).

Who is sponsoring clinical trial NCT02111993?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02111993 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.